IBDEI0VO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15620,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,15620,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,15621,0)
 ;;=490.^^89^911^18
 ;;^UTILITY(U,$J,358.3,15621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15621,1,4,0)
 ;;=4^490.
 ;;^UTILITY(U,$J,358.3,15621,1,5,0)
 ;;=5^Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,15621,2)
 ;;=^17164
 ;;^UTILITY(U,$J,358.3,15622,0)
 ;;=682.8^^89^911^21
 ;;^UTILITY(U,$J,358.3,15622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15622,1,4,0)
 ;;=4^682.8
 ;;^UTILITY(U,$J,358.3,15622,1,5,0)
 ;;=5^Cellulitis NEC
 ;;^UTILITY(U,$J,358.3,15622,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,15623,0)
 ;;=585.9^^89^911^22
 ;;^UTILITY(U,$J,358.3,15623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15623,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,15623,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,15623,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,15624,0)
 ;;=428.0^^89^911^19
 ;;^UTILITY(U,$J,358.3,15624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15624,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,15624,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,15624,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,15625,0)
 ;;=496.^^89^911^20
 ;;^UTILITY(U,$J,358.3,15625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15625,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,15625,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,15625,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,15626,0)
 ;;=414.01^^89^911^23
 ;;^UTILITY(U,$J,358.3,15626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15626,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,15626,1,5,0)
 ;;=5^Coronary Artery Disease
 ;;^UTILITY(U,$J,358.3,15626,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,15627,0)
 ;;=311.^^89^911^25
 ;;^UTILITY(U,$J,358.3,15627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15627,1,4,0)
 ;;=4^311.
 ;;^UTILITY(U,$J,358.3,15627,1,5,0)
 ;;=5^Depression
 ;;^UTILITY(U,$J,358.3,15627,2)
 ;;=^35603
 ;;^UTILITY(U,$J,358.3,15628,0)
 ;;=250.01^^89^911^26
 ;;^UTILITY(U,$J,358.3,15628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15628,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,15628,1,5,0)
 ;;=5^Diabetes, Type 1
 ;;^UTILITY(U,$J,358.3,15628,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,15629,0)
 ;;=250.00^^89^911^27
 ;;^UTILITY(U,$J,358.3,15629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15629,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,15629,1,5,0)
 ;;=5^Diabetes, Type 2
 ;;^UTILITY(U,$J,358.3,15629,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,15630,0)
 ;;=305.90^^89^911^29
 ;;^UTILITY(U,$J,358.3,15630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15630,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,15630,1,5,0)
 ;;=5^Drug Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,15630,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,15631,0)
 ;;=305.93^^89^911^28
 ;;^UTILITY(U,$J,358.3,15631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15631,1,4,0)
 ;;=4^305.93
 ;;^UTILITY(U,$J,358.3,15631,1,5,0)
 ;;=5^Drug Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,15631,2)
 ;;=^268261
 ;;^UTILITY(U,$J,358.3,15632,0)
 ;;=796.2^^89^911^33
 ;;^UTILITY(U,$J,358.3,15632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15632,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,15632,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,15632,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,15633,0)
 ;;=607.84^^89^911^35
 ;;^UTILITY(U,$J,358.3,15633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15633,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,15633,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,15633,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,15634,0)
 ;;=530.81^^89^911^36
 ;;^UTILITY(U,$J,358.3,15634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15634,1,4,0)
 ;;=4^530.81
